Lithotripsy or Ureteroscopy for Kidney Stones Denied by Insurance? How to Appeal

Kidney stone procedures — including extracorporeal shock wave lithotripsy (ESWL) and ureteroscopy with laser lithotripsy — are effective, well-established treatments for nephrolithiasis. When a urologist recommends intervention, an insurance denial can be both frustrating and painful (literally). Understanding why denials happen and how to counter them is the key to getting the care you need.

Why Kidney Stone Treatment Claims Get Denied

Stone size criteria not met. Insurers use stone size as a primary criterion for determining whether intervention is medically necessary. The general rule used by most clinical guidelines (including the American Urological Association) is:

• Stones ≤4mm: high likelihood of spontaneous passage (~80%), observation recommended
• Stones 5–10mm: variable, may pass spontaneously (~50%), intervention considered if symptoms persist or passage fails
• Stones >10mm: unlikely to pass spontaneously, intervention typically recommended

Insurers may deny procedures for stones that fall in the 5–10mm range, arguing spontaneous passage should be awaited. If the stone is measured at the boundary of these thresholds, there can be disputes about measurement methodology (CT scan dimensions vs. plain film).

Observation period not completed. For smaller stones, insurers may require documentation that a watchful waiting period was attempted and failed before approving intervention. If your urologist scheduled the procedure promptly due to symptoms or clinical concern, the insurer may deny it.

Imaging not provided or not current. Recent imaging — typically a CT scan without contrast (the gold standard) — is required to document stone size, location, and anatomy. If only older imaging is available, or if the imaging doesn't clearly characterize the stone, the insurer may deny the procedure.

Stone location disputes. The location of a stone within the urinary tract affects both the likelihood of spontaneous passage and the choice of procedure. Stones in the distal ureter pass more often than proximal ureteral or intrarenal stones. Insurers may argue that a distal ureteral stone of a given size is more likely to pass than a proximal stone of the same size, and deny intervention accordingly.

Procedure type not matched to stone characteristics. Insurers may approve one type of procedure but not another. For example, ESWL may be approved for a proximal ureteral stone, but ureteroscopy may be denied as "not necessary" when ESWL was available. If your urologist chose ureteroscopy based on stone hardness (Hounsfield units on CT) or anatomy, the rationale should be documented.

Emergency vs. elective classification. Kidney stones complicated by infection (struvite stones, obstruction with pyelonephritis) or causing complete ureteral obstruction are urological emergencies requiring urgent decompression — either via ureteral stent or percutaneous nephrostomy — before or with stone removal. Insurers may dispute whether emergency intervention was truly urgent.

Percutaneous nephrolithotomy (PCNL) for large stones. PCNL is the standard treatment for staghorn calculi and large renal stones (>2cm). Insurers may require documentation that ESWL or ureteroscopy are not appropriate alternatives before approving PCNL.

Building Your Appeal

Provide the CT scan report with stone measurements. The CT report should include stone size in millimeters, stone location (upper/mid/lower calyx, ureteropelvic junction, proximal/mid/distal ureter), Hounsfield units (stone density, which predicts ESWL success), and any obstructive changes (hydronephrosis, perinephric stranding).

Document symptom burden. The medical record should show the frequency and severity of pain episodes, ED visits or urgent care visits for pain management, nausea, vomiting, and functional impairment. A stone that has been causing repeated symptomatic episodes is a stronger indication for intervention than one discovered incidentally.

Include any laboratory evidence of infection or obstruction. Urinalysis, urine culture, leukocytosis, and renal function (creatinine) changes support urgent or semi-urgent intervention.

Get a letter from your urologist. The letter should explain stone size and location, why spontaneous passage is unlikely or inappropriate in your case (anatomy, prior failure to pass, recurrent episodes, infection risk), the procedure chosen and why it is most appropriate for your stone characteristics, and AUA guideline support.

Address the watchful waiting argument. If the insurer argues that observation should have been attempted first, document why this wasn't appropriate: the stone is in a location unlikely to pass, you have a solitary kidney, you've had prior ureteral stricture, your stone is hardness-resistant to ESWL, or you've already had prolonged symptoms.

After an Internal Denial

Request external independent review by a urologist. Stone procedure denials based on stone size or observation periods are among the most straightforward to overturn when the clinical record is complete.

Fight Back With ClaimBack

Kidney stones are notoriously painful, and you deserve treatment — not an insurance battle. ClaimBack helps you build the complete appeal your insurer needs to cover your procedure.

Start your appeal at ClaimBack

Related Reading

• What Is Medical Necessity?
• How to Write an Insurance Appeal Letter
• Common Reasons Insurance Claims Are Denied